Efficacy of L/A Spray andL/A-soaked Nasal Packings on Postoperative Pain After Nasal Closed Reduction

Nasal Fracture Clinical Trial

Official title:

Efficacy of Preoperative Lidocaine Spray and Local Aensthetics-soaked Nasal Packings on Postoperative Pain After Nasal Closed Reduction

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03733275
• Other study ID #: yemoon
• Status: Completed
• Phase: N/A
• Start date: December 3, 2018
• Est. completion date: May 31, 2019

Study information

• Verified date: February 2021
• Source: The Catholic University of Korea
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study is perfored to investigate the efficacy of preoperative lidocaine spray and lidocaine-bupivacaine mixture-soaked nasal packing for acute postoperative pain after nasal closed reduction surgery.

Description:

To investigate the treatment of postoperative pain after nasal closed reduction surgery, we plan to investigate the effect of preoperative lidocaine spray and lidocaine-bupivacaine mixture-soaked nasal packing for the patinets undergoing nasal closed reduction under general aensthesia, compaing to the control group (normal saline spray and normal saline-soaked nasal packing).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 33
• Est. completion date: May 31, 2019
• Est. primary completion date: April 30, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• patients scheduled to receive nasal reduction surgery under general aensthesia

Exclusion Criteria:

• concomitant disorders (eg. facial bone fractures) concomitant surgery (eg. septoplasty)

Related Conditions & MeSH terms

• Nasal Fracture
• Pain, Postoperative

Intervention

Drug:
• Lidocaine
for experimental arm, lidocaine spray and lidocaine bupivacine mixture-soaked nasal packing vs. for placebo arm, normal saline spray and packing

Locations

Country	Name	City	State
Korea, Republic of	Seoul St.Mary's Hospital	Seoul	Seocho-gu
Korea, Republic of	Seoul St.Mary's Hospital	Seoul	Seocho-gu

Sponsors (1)

Lead Sponsor	Collaborator
The Catholic University of Korea

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	postoperative pain in recovery room	Using VAS, postoperative pain is measured.	immediately after surgery
Secondary	rescue analgesics in recovery room	Fentanyl iv injection for pain control is checked.	1 hr after surgery